To hear about similar clinical trials, please enter your email below
Trial Title:
Project PLUS Lung Cancer Screening Promotion
NCT ID:
NCT05937399
Condition:
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Conditions: Keywords:
Screening
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Health Services Research
Masking:
Single (Participant)
Intervention:
Intervention type:
Behavioral
Intervention name:
Intervention video
Description:
This intervention is an integrated health video provides individual (smoking) and
environmental risk communication on intention to obtain lung cancer screening.
Arm group label:
Intervention Arm
Intervention type:
Behavioral
Intervention name:
Control video
Description:
This intervention is an integrated health video provides individual (smoking) risk
communication on intention to obtain lung cancer screening.
Arm group label:
Control Video Arm
Summary:
Project PLUS is a pilot study that aims to develop and obtain preliminary feasibility and
efficacy data on an enhanced risk communication approach to promote lung cancer screening
(LCS) intentions among screening-eligible individuals from environmentally burdened
communities. Project PLUS will combine qualitative interviews to explore subject
awareness regarding lung cancer risk and air pollution, barriers to LCS, and perceptions
regarding risk communication messaging, develop a health education video, and a
between-subjects experiment to compare Data from this pilot will form the basis for
enhanced community engagement efforts and subsequent communication research to examine
the effectiveness of incorporating the involuntary air pollution risk information in risk
communication interventions. The long term goal is to reduce lung cancer burden and
disparities among environmentally burdened communities within and outside of
Philadelphia.
Detailed description:
Project PLUS is a pilot study that aims to develop and obtain preliminary feasibility and
efficacy data on an enhanced risk communication approach to promote lung cancer screening
(LCS) intentions among screening-eligible individuals from environmentally burdened
communities. Project PLUS will combine qualitative interviews to explore subject
awareness regarding lung cancer risk and air pollution, barriers to LCS, and perceptions
regarding risk communication messaging, develop a health education video, and a
between-subjects experiment to compare Data from this pilot will form the basis for
enhanced community engagement efforts and subsequent communication research to examine
the effectiveness of incorporating the involuntary air pollution risk information in risk
communication interventions. The long term goal is to reduce lung cancer burden and
disparities among environmentally burdened communities within and outside of
Philadelphia.
This study is guided by the Health Belief Model and the Reasoned Action Approach.1 The
study team will engage with two community partner organizations (Chester Environmental
Partnership and Clean Water Action) to obtain feedback in implementing the study
procedures and input on content for the health education video. The long-term goal is to
improve LCS and reduce racial, ethnic, and socioeconomic disparities in lung cancer
mortality.
Criteria for eligibility:
Criteria:
Patient interview participants will be eligible if they:
1. Are ages 50 - 80 years;
2. Have a history of at least 20 cigarette pack-years, and who have quit within the
past 15 years or are currently smoking;
3. Had a primary care visit at Penn Medicine within the last two years (2020-2021);
4. Have documented history of lung cancer screening or lung cancer
5. Are residing in one of 10 eligible zip codes;
6. Are English-speaking;
7. Are able to view the study videos;
8. Are able to participate in a video-conference interview using a HIPAA-compliant
platform or able to participate in an interview over the phone.
Pilot trial participants will be eligible if they:
1. Are ages 50 - 80 years;
2. Are documented history of at least 20 cigarette pack-years, and who have quit within
the past 15 years or are currently smoking;
3. Have no documented history of lung cancer screening or lung cancer;
4. Did not participate in patient interviews;
5. Had a primary care visit at Penn Medicine within the last two years (2020-2022);
6. Are residing in one of 10 eligible zip codes;
7. Are English-speaking;
8. Are able to view the study videos and complete an online survey.
Key Exclusion Criteria:
Patient interview participants are excluded if:
a. They are not eligible for lung cancer screening.
Pilot trial participants are excluded if they:
1. Do not meet inclusion criteria;
2. Participated in patient interviews.
Gender:
All
Minimum age:
50 Years
Maximum age:
80 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
University of Pennsylvania
Address:
City:
Philadelphia
Zip:
19104
Country:
United States
Start date:
December 2, 2022
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Abramson Cancer Center at Penn Medicine
Agency class:
Other
Source:
Abramson Cancer Center at Penn Medicine
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05937399
